SCHEMBL1003068

SCHEMBL1003068

COc1ccc(-c2nccc(N)c2N)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 2/20 0.53
KDM4E B2RXH2 3/20 0.51
ALDH1A1 P00352 3/20 0.51
HPGD P15428 1/20 0.51
KMT2A Q03164 2/20 0.49
CLK4 Q9HAZ1 1/20 0.47
PDE3B Q13370 1/20 0.47
PDE3A Q14432 1/20 0.47
ADORA1 P30542 1/20 0.45
MAPT P10636 2/20 0.44
MEN1 O00255 1/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
PTGS2 P35354 1/20 0.44
ADORA2A P29274 1/20 0.43
NOS3 P29474 1/20 0.43
NOS1 P29475 1/20 0.43
NOS2 P35228 1/20 0.43
MAT2A P31153 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5322929 0.83 DYRK1A (0.50) DYRK1AKDM4EALDH1A1HPGDKMT2A
SCHEMBL30622627 0.80 DYRK1A (0.54) DYRK1AKDM4EALDH1A1HPGDKMT2A
SCHEMBL18448865 0.80 DYRK1A (0.54) DYRK1AKDM4EALDH1A1HPGDKMT2A
SCHEMBL10429366 0.79 ADORA1 (0.54) DYRK1AKDM4EALDH1A1HPGDKMT2A
SCHEMBL30610433 0.79 KDM4E (0.65) DYRK1AKDM4EALDH1A1HPGDKMT2A
SCHEMBL1551352 0.79 KDM4E (0.65) DYRK1AKDM4EALDH1A1HPGDKMT2A
SCHEMBL20522349 0.78 KDM4E (0.54) DYRK1AKDM4EALDH1A1HPGDKMT2A
SCHEMBL30610423 0.78 KDM4E (0.54) DYRK1AKDM4EALDH1A1HPGDKMT2A
SCHEMBL18447982 0.78 TDP1 (0.61) DYRK1AKDM4EALDH1A1HPGDKMT2A
SCHEMBL17555811 0.78 KDM1A (0.45) DYRK1AADORA1PTGS2ADORA2ANOS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 586 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3464247-B1 NOVEL OXIDATION BASE DERIVED FROM 1-HEXYL-4,5- DIAMINOPYRAZOLE, COMPOSITION CONTAINING SAME AND USE THEREOF IN OXIDATION DYEING OF KERATIN FIBRES OREAL (FR) 2020-03-11 EP claimed
US-7189267-B2 Oxyethylenated based hair pre-treatment anti-penetration composition and method using such a composition for limiting the penetration of dyes into the skin L'OREAL (FR) 2007-03-13 US claimed
US-7179301-B2 Dyeing compositions for keratinous fibers containing paraphenylenediamine derivatives with pyrrolidinyl group L'OREAL S.A. (FR) 2007-02-20 US claimed
US-6723136-B2 PRECURSOR OF AROMATIC RINGS HAVING HYDROXYL GROUPS ON ADJACENT CARBON ATOMS, AND OXIDATION BASE OF PARA OR ORTHO AROMATIC AMINES, AND A CATALYTIC SYSTEM OF SALTS AND OXIDES OF MANGANESE AND ZINC L'OREAL (FR) 2004-04-20 US claimed
EP-1367983-A1 MICROCAPSULES WITH AQUEOUS CORE CONTAINING OXIDATION-REDUCTION ENZYMES AND THEIR USE IN OXIDATION DYEING COMPOSITIONS L'OREAL (FR) 2003-12-10 EP claimed
US-20030172472-A1 Oxidaton dyeing composition for keratinous fibres comprising an amphoteric polymer with fatty chain L'OREAL S.A. (FR) 2003-09-18 US claimed
CN-1440267-A Oxidation dyeing composition for keratinous fibres comprising amphoteric polymer with fatty chain OREAL (FR) 2003-09-03 CN claimed
EP-0994692-B1 OXIDATION DYEING COMPOSITION FOR KERATINOUS FIBRES CONTAINING A 3-AMINOPYRIDINE AZO DERIVATIVE AND DYEING METHOD USING SAID COMPOSITION OREAL (FR) 2003-04-23 EP claimed
WO-2002069922-A1 MICROCAPSULES WITH AQUEOUS CORE CONTAINING OXIDATION-REDUCTION ENZYMES AND THEIR USE IN OXIDATION DYEING COMPOSITIONS L'OREAL (FR) 2002-09-12 WO claimed
CN-1258214-A Oxidation dyeing composition for keratinous fibres contg. 3-aminopyridine azo deriv. and dyeing method using said composition OREAL (FR) 2000-06-28 CN claimed
CN-118103023-A Retarder composition and dye set comprising same 莱雅公司 2024-05-28 CN disclosed
CN-118043027-A Process for dyeing and/or lightening keratin fibres 莱雅公司 2024-05-14 CN disclosed
CN-112312883-B Device for dispensing hair coloring products using dye compositions and oxidizing compositions comprising scleroglucan gum 莱雅公司 2024-04-02 CN disclosed
CN-117715610-A Composition for simultaneously bleaching and dyeing keratin fibers and method for using same 莱雅公司 2024-03-15 CN disclosed
CN-117715615-A Composition comprising at least one oxidation dye, 1, 3-propanediol, at least one alkaline agent and at least one fatty substance 莱雅公司 2024-03-15 CN disclosed
CN-1241137-A Composition for the oxidation dyeing of keratin fibres and dyeing process using this composition OREAL (FR) 2000-01-12 CN disclosed
CN-1241138-A Oxidation dyeing composition for keratin fibres and dyeing method using said composition OREAL (FR) 2000-01-12 CN disclosed
CN-1241135-A Oxidation dyeing composition for keratin fibres OREAL (FR) 2000-01-12 CN disclosed
CN-1239422-A Oxidation dyeing compsn. for keratin fibres and dyeing method of using same OREAL (FR) 1999-12-22 CN disclosed
CN-1236609-A Oxidation dyeing composition of keration fibre and dyeing method using same OREAL (FR) 1999-12-01 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030172472-A1 Oxidaton dyeing composition for keratinous fibres comprising an amphoteric polymer with fatty chain KRT18, MB, MDN1 DYRK1A 2799/4885KDM4E 2014/4885ALDH1A1 566/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.